News and Announcements
Leaf & Andritz Complete Successful Evaluation of Glycell™ Evaluation on EFB
- Published March 21, 2016 3:10PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th March 2016, ASX Announcement
Highlights:
- Joint evaluation by Leaf and Adritz show improved recovery of sugars using Glycell™ process
- Andritz nominates Leaf’s Glycell™ process as one of its preferred pretreatments of Empty Fruit Bunch Biomass
Leaf Resources and Andritz (a globally leading supplier of plant, equipment, and services for pulp and paper and other industries) undertook work to evaluate Glycell™ pretreatment technology on the specific biomass known as Empty Fruit Bunch Biomass (EFB) at pilot scale in Springfield, Ohio.
EFB is an abundant, low cost feedstock in palm oil producing countries like Malaysia, Indonesia, Thailand and others. Approximately 20 million metric tons are “generated”annually by palm oil mills in Malaysia, between 22-23 million metric tons in Indonesia and over 2 million tons in Thailand.
To view the full article please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
